People

Asim Farooq, MD

  • Professor of Ophthalmology and Visual Science
  • Clinical Interests: Blurred Vision, Cataracts, Conjunctivitis, Cornea and External Eye Diseases, Corneal Infections, Diabetic Eye Diseases, Dry Eye Syndrome, Glaucoma, Graft Versus Host Disease GVHD, Herpes Simplex, Herpes Zoster, Macular Degeneration, Red Eyes
  • Research and Scholarly Interests: Graft Versus Host Disease (GVHD), Herpes Simplex, Herpes Zoster, Ocular Surface Disease
  • Websites: The University of Chicago Department of Ophthalmology, Research Network Profile
  • Contact: afarooq@bsd.uchicago.edu

Washington University
St. Louis, MO
Fellowship - Cornea
2016

Univerity of Illinois at Chicago College of Medicine
Chicago, IL
Residency - Ophthalmology
2015

St. Francis Hospital
Evanston, IL
Internship - Transitional Year
2012

University of Illinois at Chicago College of Medicine
Chicago, IL
MD - Medicine
2011

University of Illinois at Chicago College of Medicine
Chicago, IL
Research Fellowship - Prevent Blindness
2010

Bilateral Secondary Glaucoma Associated with Congenital Herpes Simplex Virus Keratitis: A Case Report and Review of the Literature.
Bilateral Secondary Glaucoma Associated with Congenital Herpes Simplex Virus Keratitis: A Case Report and Review of the Literature. Ocul Immunol Inflamm. 2025 Nov; 33(9):2221-2223.
PMID: 40899417

Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events.
Practical Guidance on Clinical Management of Belantamab Mafodotin-Associated Ocular Events. Am J Hematol. 2025 Oct; 100(10):1839-1850.
PMID: 40717676

Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma.
Characterization of Belantamab Mafodotin-Induced Corneal Changes in Patients With Multiple Myeloma. JAMA Ophthalmol. 2025 06 01; 143(6):507-514.
PMID: 40338596

Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab.
Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab. Ophthalmol Ther. 2025 Jul; 14(7):1349-1356.
PMID: 40355729

Herpesvirus Infections of the Corneal Endothelium.
Herpesvirus Infections of the Corneal Endothelium. Microorganisms. 2025 Mar 28; 13(4).
PMID: 40284615

Diagnostic approach to limbal stem cell deficiency.
Diagnostic approach to limbal stem cell deficiency. Front Ophthalmol (Lausanne). 2024; 4:1524595.
PMID: 39886446

Ocular surface disease related to tisotumab vedotin-tftv.
Ocular surface disease related to tisotumab vedotin-tftv. Gynecol Oncol Rep. 2025 Feb; 57:101676.
PMID: 39877468

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies.
Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies. Oncologist. 2024 Nov 04; 29(11):e1435-e1451.
PMID: 39046895

Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs).
Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs). Curr Ophthalmol Rep. 2024 Jun; 12(2):13-22.
PMID: 38756824

Reply to Comment on: Noninfectious Outcomes of Intravitreal Antibiotic-Steroid Injection and Topical NSAID Versus Triple Drop Therapy Postcataract Surgery.
Reply to Comment on: Noninfectious Outcomes of Intravitreal Antibiotic-Steroid Injection and Topical NSAID Versus Triple Drop Therapy Postcataract Surgery. Am J Ophthalmol. 2024 04; 260:215-216.
PMID: 38281566

View All Publications

Claes Dohlman Fellowship Award
2018

Respect and Compassion Award
The University of Chicago, Department of Ophthalmology and Visual Science
2018

Information For Patients